Rossella E. Nappi

TL;DR: There is strong evidence that estrogen therapy may partly prevent this menopause-related change in body composition and the associated metabolic sequelae and further studies are required to identify the women most likely to gain metabolic benefit from menopausal hormone therapy in order to develop evidence-based clinical recommendations.

TL;DR: It is demonstrated that although men show an age-related decrease, serum allopregnanolone levels in women do not change with age and correlate with P levels during the menstrual cycle and in response to endocrine tests.

TL;DR: It was found that 60% of the women with sexual arousal disorders and 61% of those with sexual pain disorders also complained of recurrent bacterial cystitis, and women reporting low sexual desire commonly suffered from stress incontinence.

TL;DR: Postmenopausal women have a low understanding of vaginal atrophy, and medical practitioners should proactively raise this topic, help patients to understand that vaginalatrophy is a chronic condition, and discuss treatment options.

TL;DR: Certain risk factors for lack of improvement of migraine during pregnancy were identified: the presence of menstrually related migraine before pregnancy was associated with a lack of headache improvement in the first and third trimesters, while second-trimester hyperemesis, and a pathological pregnancy course were associated with an absence of headache improved in the second trimester.